Trials.ai favicon

Trials.ai

Trials.ai screenshot
Click to visit website
Feature this AI

About

Trials.ai is an intelligent study design platform created to modernize the manual processes involved in clinical research. By digitizing and automating the creation of clinical documents, the platform helps life science companies transition from document-driven workflows to data-driven environments. It leverages state-of-the-art Natural Language Processing (NLP) and Machine Learning (ML) to provide an end-to-end connected process for developing trial protocols. The ultimate goal is to accelerate the timeline for bringing new treatments to patients by removing traditional data silos and information bottlenecks. The platform operates by mining vast amounts of trial-related documentation from both internal customer repositories and public domain sources. This data forms the foundation for the Smart Study platform, which utilizes a specialized Clinical Trials Ontology for high-precision training and tuning. The system analyzes various protocol components, including objectives, endpoints, inclusion/exclusion criteria, and outcome measurements. By cross-comparing this data across all therapeutic areas, medical journals, and regulatory guidances, the platform's unique ML algorithms can flag potential threats, identify likely amendments, and provide actionable recommendations for optimization. Trials.ai is primarily built for research and development teams within pharmaceutical companies, biotechnology firms, and clinical research organizations (CROs). It is particularly effective for study designers and clinical operations leads who need to manage trial complexity while keeping patient needs at the forefront. Because the system can connect directly to downstream systems, it is also beneficial for teams looking to speed up study startup and reduce manual data entry errors. The platform's ability to provide a second opinion based on historical data makes it a valuable tool for any life science professional involved in protocol development. What distinguishes Trials.ai is its specific focus on the intersection of speed, cost, risk, and patient-centricity. While many tools focus solely on data management, Trials.ai uses predictive modeling to assess how specific design decisions will impact the likelihood of a trial's success. Its acquisition by ZS in 2023 further strengthens its position by integrating its technology into a broader ecosystem of life sciences consultancy and analytics. The platform's emphasis on reducing patient burden highlights a commitment to human-centric design, ensuring that trials are not only efficient but also accessible for those participating in them.

Pros & Cons

Accelerates study startup by connecting optimized protocols directly to downstream systems.

Reduces trial complexity by using ML algorithms to flag potential pitfalls and threats early.

Increases patient centricity by analyzing and minimizing patient burden within study designs.

Leverages a specialized Clinical Trials Ontology for high-precision, targeted recommendations.

Aggregates insights from both private repositories and extensive public domain medical literature.

Pricing information is not publicly listed and requires a direct inquiry.

Advanced algorithms for analyzing trial amendments were noted as being under development.

Standalone availability may be affected by its acquisition by ZS.

Use Cases

Clinical Operations Leads can use the platform to automate the creation of study protocols, significantly reducing the manual effort required for document preparation.

Study Designers can leverage the AI's second opinion to compare their criteria against historical data and regulatory guidances across all therapeutic areas.

Research Teams can identify and mitigate potential risks such as high patient burden or likely protocol amendments before the trial begins.

Pharma Companies can speed up the trial-ready phase by using the platform to bridge the gap between initial research and study startup.

Platform
Web
Task
clinical protocol optimizing

Features

therapeutic area cross-comparison

downstream system connectivity

patient burden assessment algorithms

predictive risk and pitfall flagging

inclusion and exclusion criteria optimization

clinical trials ontology for precise training

nlp-driven data mining of trial documents

automated clinical document creation

FAQs

What is the main purpose of the Trials.ai platform?

The platform is designed to automate and optimize the creation of clinical trial protocols using AI to reduce timelines and costs. It helps research teams transition from manual, document-driven environments to integrated, data-driven systems.

How does the AI help in designing a clinical study?

The system uses NLP and Machine Learning to analyze components like inclusion/exclusion criteria and endpoints. It identifies potential risks and provides recommendations based on a specialized Clinical Trials Ontology and cross-comparison of therapeutic data.

Who can benefit from using Trials.ai?

Life science companies, particularly research teams and clinical trial planners, use the platform to improve study startup speed and trial outcomes. It is suitable for professionals across all therapeutic areas looking for a data-backed second opinion on protocol design.

Does the platform integrate with existing research systems?

Yes, Trials.ai is built to connect to downstream systems to speed up the study startup process and minimize manual inputs. This ensures that the optimized protocol data feeds directly into the systems used for executing the trial.

What data sources does the platform use for its insights?

The platform mines massive amounts of trial-related documents from both private customer repositories and the public domain. This includes past trial data, medical journals, regulatory agency guidances, and thought-leader articles.

Job Opportunities

There are currently no job postings for this AI tool.

Explore AI Career Opportunities

Social Media

Ratings & Reviews

No ratings available yet. Be the first to rate this tool!

Featured Tools

adly.news favicon
adly.news

Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.

View Details
Atoms favicon
Atoms

Launch full-stack products and acquire customers in minutes using a coordinated team of AI agents that handle everything from deep research to SEO and coding.

View Details
Atomic Mail favicon
Atomic Mail

Protect your data with end-to-end encryption and an AI suite that drafts, summarizes, and scans emails for sensitive content to ensure maximum privacy.

View Details
Rekap favicon
Rekap

Turn every meeting, call, and document into actionable takeaways with AI-powered transcription and custom automation tools designed for fast-moving teams.

View Details
Sketch To favicon
Sketch To

Convert images into artistic sketches or transform hand-drawn drafts into realistic photos using advanced AI models designed for artists, designers, and hobbyists.

View Details
Seedance 4.0 favicon
Seedance 4.0

Create high-definition AI videos from text prompts or images in seconds with built-in audio, commercial rights, and support for multiple cinematic models.

View Details
Seedance favicon
Seedance

Transform text prompts or static images into cinematic 1080p videos with fluid motion and consistent multi-shot storytelling for creators and brands.

View Details